Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Novel Marek’s disease vaccines now available in the UK
Boehringer Ingelheim states that the PREVEXXION RN range provides full protection of broilers, layers and breeders against the most virulent Marek's disease virus strains.

New product described as “the first innovation in the Marek category in over 40 years.”

Boehringer Ingelheim has announced the launch of a new set of Marek's disease vaccines in the UK and the EU, named PREVEXXION RN and PREVEXXION RN+HVT+IBD.

The World Organisation for Animal Health (OIE) describes Marek's disease as a major economic risk for poultry flocks, particularly those of young adult fowls about to be utilised for meat or egg production. Vaccination against Marek's disease can considerably reduce mortality.

The PREVEXXION RN range is made up of an innovative serotype-1 construct vaccine. According to Boehringer Ingelheim, its early Marek’s disease onset of immunity from five days of age provides full protection of broilers, layers and breeders against the most virulent Marek’s disease virus strains.

It is also fully compatible with VAXXITEK HVT+IBD and is available as a 3-in-1 solution – named PREVEXXION RN+HVT+IBD – specifically designed to provide protection from the hatchery.

Jerôme Baudon, head of poultry at Boehringer Ingelheim, called PREVEXXION RN the “new golden standard” for Marek's disease vaccination programs. He said: “Our PREVEXXION RN range provides value through innovation to Marek sensitive poultry producers looking for continuous live production productivity improvement and effective protection.

“Field and lab experiments conducted worldwide demonstrated its safety, efficacy and its strong, early, and long-lasting protection through the lifespan of the birds and against very virulent Marek’s disease challenge.”

PREVEXXION RN vaccines are available in ampoules of 1000, 2000, and 4000 doses, frozen in liquid nitrogen. For more information please contact your Boehringer Ingelheim representative.

Become a member or log in to add this story to your CPD history

Budding 'Dr Dolittles' sought for writing competition

News Story 1
 Vets are being invited to enter a writing competition run by the Page Turner Awards for a chance to get their story published or even made into a film.

Dubbed the 'Rolls Royce' of writing awards, the Page Turner competition provides an opportunity for aspiring writers to submit unpublished fiction and non-fiction work to be read by a panel of influential players in the publishing industry.

A spokesperson said: 'Do you think of yourself as a magical healer, like Dr Dolittle. Or maybe you have a story to share about the times when, sadly, animals can't be treated, and pet owners reflect on those moments they took for granted."

For more information, visit pageturnerawards.com 

Click here for more...
News Shorts
Avian influenza confirmed in Lancashire

A case of highly pathogenic (HPAI H5N8) avian influenza has been confirmed in two captive peregrine falcons on a non-commercial, non-poultry premises near Skelmersdale, West Lancashire.

Following a risk assessment, APHA has declared that no disease control zones have been put in place surrounding this non-commercial, non-poultry premises.

Eighteen cases of HPAI H5N8 have now been identified in poultry and other captive birds in England. A housing order for poultry and captive birds introduced by Defra to control the spread of the disease expired on 31 March, although bird keepers in England are still required by law to comply with biosecurity measures.

For more information, please click here.